January 24, 2015 - Loews Hotel, Minneapolis, MN

Course Directors: Habermann, Thomas M., M.D., Witzig, Thomas E., M.D.

This one-day program provides hematology and oncology clinicians, nurse practitioners and physician assistants with an overview of the most recent advances in the treatment of various hematologic malignancies, based on abstracts presented at the December 2014 annual meeting of the American Society of Hematology (ASH). Invited speakers choose exciting and relevant abstracts presented at the ASH meeting and discuss their clinical relevance to the hematology/oncology practice.

Learning Objectives
Upon conclusion of this program, participants should be able to:

• Describe the results of important disease-specific clinical trials presented at the American Society of Hematology Annual Meeting in 2014, putting them into clinical context and into the perspective of current clinical practice guidelines
• Identify investigational therapeutic regimens that are available as alternatives to standard of care approaches
• Compare current clinical practice with the advances and new knowledge in managing various hematological malignancies that are presented at the American Society of Hematology meeting or that have been published over the last 12 months​

Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.

Credit Information

Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mayo Clinic College of Medicine designates this live activity for 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.

Course summary